Cargando…

Effect of Dicycloplatin, a Novel Platinum Chemotherapeutical Drug, on Inhibiting Cell Growth and Inducing Cell Apoptosis

Dicycloplatin, a new supramolecular platinum-based antitumor drug, has been approved by the State Food and Administration (SFDA) of China. In this study, we investigated the anticancer activity of dicycloplatin in cancer cells and signaling pathways involved in dicycloplatin-induced apoptosis. Dicyc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Guang-quan, Chen, Xing-gui, Wu, Xing-ping, Xie, Jing-dun, Liang, Yong-ju, Zhao, Xiao-qin, Chen, Wei-qiang, Fu, Li-wu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495782/ https://www.ncbi.nlm.nih.gov/pubmed/23152837 http://dx.doi.org/10.1371/journal.pone.0048994

Ejemplares similares

Predictive Biomarkers of Dicycloplatin Resistance or Susceptibility in Prostate Cancer
por: Liu, Minglu, et al.
Publicado: (2021)

A double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung cancers
por: Liu, Ke-Jun, et al.
Publicado: (2014)

A novel platinum-based chemotherapeutic inducing immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2020)

STATing the importance of immune modulation by platinum chemotherapeutics
por: Hato, Stanleyson V., et al.
Publicado: (2012)

Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents
por: Gersten, Benjamin K., et al.
Publicado: (2020)

BIRB796, the Inhibitor of p38 Mitogen-Activated Protein Kinase, Enhances the Efficacy of Chemotherapeutic Agents in ABCB1 Overexpression Cells
por: He, Dan, et al.
Publicado: (2013)

New Perfluorophtalate Complexes of Platinum(II) With Chemotherapeutic Potential
por: de Oliveira, M. B., et al.
Publicado: (1996)

Apoptosis of CD19(+) chimeric antigen receptor T cells after treatment with chemotherapeutic agents
por: Yi, Wenfang, et al.
Publicado: (2018)

Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics
por: Ferraro, Maria Grazia, et al.
Publicado: (2022)

Lapatinib promotes the incidence of hepatotoxicity by increasing chemotherapeutic agent accumulation in hepatocytes
por: Dai, ChunLing, et al.
Publicado: (2015)

Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients
por: Liu, Rong, et al.
Publicado: (2017)

Characterization in Dual Activation by Oxaliplatin, a Platinum-Based Chemotherapeutic Agent of Hyperpolarization-Activated Cation and Electroporation-Induced Currents
por: Chang, Wei-Ting, et al.
Publicado: (2020)

Comparative Study of the Mode of Action of Clinically Approved Platinum-Based Chemotherapeutics
por: Schoch, Sarah, et al.
Publicado: (2020)

GSDME Increases Chemotherapeutic Drug Sensitivity by Inducing Pyroptosis in Retinoblastoma Cells
por: Li, Fang, et al.
Publicado: (2022)

Cepharanthine sensitizes human triple negative breast cancer cells to chemotherapeutic agent epirubicin via inducing cofilin oxidation-mediated mitochondrial fission and apoptosis
por: Shen, Li-wen, et al.
Publicado: (2021)

First and Second Line Chemotherapeutic Regimens for Non-Small Cell Lung Carcinomas - The Efficacy of Platinum, Non-Platinum and Combination Therapy: A Literature Review
por: Michael, Anita, et al.
Publicado: (2020)

Knockdown of the Inhibitor of Apoptosis BRUCE Sensitizes Resistant Breast Cancer Cells to Chemotherapeutic Agents
por: Garrison, Jason B, et al.
Publicado: (2015)

Antioxidant Supplementation in the Treatment of Neurotoxicity Induced by Platinum-Based Chemotherapeutics—A Review
por: Stankovic, Jelena S. Katanic, et al.
Publicado: (2020)

The Role of mTORC1 Pathway and Autophagy in Resistance to Platinum-Based Chemotherapeutics
por: Pan, Zhenrui, et al.
Publicado: (2023)

CD9 knockdown suppresses cell proliferation, adhesion, migration and invasion, while promoting apoptosis and the efficacy of chemotherapeutic drugs and imatinib in Ph(+) ALL SUP-B15 cells
por: Xing, Chongyun, et al.
Publicado: (2020)

The role of expression and polymorphism of the BAG-1 gene in response to platinum-based chemotherapeutics in NSCLC
por: WANG, YA-DI, et al.
Publicado: (2011)

Silver Nanotriangles and Chemotherapeutics Synergistically Induce Apoptosis in Glioma Cells via a ROS-Dependent Mitochondrial Pathway
por: Yang, Huiquan, et al.
Publicado: (2020)

JNJ-26481585 primes rhabdomyosarcoma cells for chemotherapeutics by engaging the mitochondrial pathway of apoptosis
por: Heinicke, Ulrike, et al.
Publicado: (2015)

Predicting chemotherapeutic response to small-cell lung cancer of platinum compounds by thallium-201 single-photon emission computerized tomography.
por: Tokuchi, Y., et al.
Publicado: (1998)

Dichloroacetate enhances the antitumor efficacy of chemotherapeutic agents via inhibiting autophagy in non-small-cell lung cancer
por: Lu, Xiao, et al.
Publicado: (2018)

Regulation of Tumor Necrosis Factor-related Apoptosis-inducing Ligand Expression in Primary Acute Leukemic Cells by Chemotherapeutics
por: Chen, Shengmei, et al.
Publicado: (2013)

Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells
por: Tzeng, Yen-Dun Tony, et al.
Publicado: (2018)

Metformin improves the sensitivity of ovarian cancer cells to chemotherapeutic agents
por: Yang, Chen, et al.
Publicado: (2019)

BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549
por: Franks, S. Elizabeth, et al.
Publicado: (2016)

Jaceosidin Induces Apoptosis in Human Ovary Cancer Cells through Mitochondrial Pathway
por: Lv, Wen, et al.
Publicado: (2008)

Tumor Cell Distinguishable Nanomedicine Integrating Chemotherapeutic Sensitization and Protection
por: Liu, Sen, et al.
Publicado: (2021)

Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells
por: Herůdková, Jarmila, et al.
Publicado: (2017)

Degradation of P-glycoprotein by pristimerin contributes to overcoming ABCB1-mediated chemotherapeutic drug resistance in vitro
por: Yan, Yan-Yan, et al.
Publicado: (2017)

RNAi-mediated silencing of the Bmi-1 gene causes growth inhibition and enhances doxorubicin-induced apoptosis in MCF-7 cells
por: Wu, Xiang-mei, et al.
Publicado: (2009)

A cell-targeted chemotherapeutic nanomedicine strategy for oral squamous cell carcinoma therapy
por: Wang, Zhi-Qi, et al.
Publicado: (2015)

A comparative analysis of the mutagenicity of platinum-containing chemotherapeutic agents reveals direct and indirect mutagenic mechanisms
por: Szikriszt, Bernadett, et al.
Publicado: (2021)

Helicobacter pylori CagA protein activates Akt and attenuates chemotherapeutics-induced apoptosis in gastric cancer cells
por: Lan, Keng-Hsueh, et al.
Publicado: (2017)

Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells
por: Wu, Shaocong, et al.
Publicado: (2018)

Crotonylated BEX2 interacts with NDP52 and enhances mitophagy to modulate chemotherapeutic agent-induced apoptosis in non-small-cell lung cancer cells
por: Mu, Ning, et al.
Publicado: (2023)

Anti-mitotic chemotherapeutics promote apoptosis through TL1A-activated death receptor 3 in cancer cells
por: Qi, Chen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8q9jptggpi4jocidq1kgfmpe36